Latest Advances

  • Condition: Refractory anti-NMDA Receptor Encephalitis
  • Journal: The Journal of international medical research
  • Treatment Used: Bilateral Salpingo-Oophorectomy and Intrathecal Injection of Methotrexate and Dexamethasone
  • Number of Patients: 1
  • Published —
This case report describes a patient with refractory anti-NMDA receptor encephalitis.
  • Condition: Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Encephalitis
  • Journal: Journal of neurology
  • Treatment Used: Bortezomib and Tramadol
  • Number of Patients: 1
  • Published —
This case report describes a 29-year-old woman diagnosed with refractory anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis treated with bortezomib and the associated movements disorders controlled with tramadol.
  • Condition: Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Encephalitis
  • Journal: BioMed research international
  • Treatment Used: Immunotherapy
  • Number of Patients: 0
  • Published —
This article discusses the current advances of prognosis-related research from the clinical manifestations of anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis.
  • Condition: Autoimmune Encephalitis
  • Journal: Nederlands tijdschrift voor geneeskunde
  • Treatment Used: Immunotherapy
  • Number of Patients: 3
  • Published —
The study describes three cases of autoimmune encephalitis due to different antibodies.
  • Condition: Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Encephalitis Induced by Bilateral Ovarian Teratomas
  • Journal: Medicine
  • Treatment Used: Tumor Resection, Immunotherapy, and Chemotherapy
  • Number of Patients: 1
  • Published —
This case report discusses a 23-year-old woman diagnosed with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis associated with ovarian teratomas.
  • Condition: Children with Anti-NMDAR Encephalitis
  • Journal: Indian pediatrics
  • Treatment Used: Immunosuppressive Therapy
  • Number of Patients: 6
  • Published —
This study reported on six children with anti-NMDAR encephalitis (brain inflammation with psychosis) who were followed-up for 6 to 24 months and treated with immunosuppressive therapy.
  • Condition: Pediatric Anti-NMDAR Encephalitis in Thailand
  • Journal: Brain & development
  • Treatment Used: First- and Second-Line Immunotherapy
  • Number of Patients: 14
  • Published —
This study described clinical manifestations, treatment outcomes, and prognostic factors in children with anti-NMDAR encephalitis.
  • Condition: Anti-N-methyl-d-aspartate (NMDA) receptor encephalitis
  • Journal: Brain stimulation
  • Treatment Used: Electroconvulsive therapy
  • Number of Patients: 30
  • Published —
This systematic review evaluated the effects of electroconvulsive therapy plus immunomodulatory therapy for the treatment of psychiatric symptoms in patients with anti-N-methyl-d-aspartate (NMDA) receptor encephalitis.
  • Condition: Severe Anti-N-Methyl-D-Aspartate Receptor (anti-NMDAR) Encephalitis Patients
  • Journal: Neurocritical care
  • Treatment Used: Combined Immunotherapy and Life Support
  • Number of Patients: 111
  • Published —
This study explored clinical characteristics and long-term outcomes of severe anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis patients.
  • Condition: Anti-N-methyl-D-aspartate Receptor Encephalitis
  • Journal: Chinese medical journal
  • Treatment Used: Intrathecal Methotrexate Treatment
  • Number of Patients: 4
  • Published —
The study researched the outcomes of intrathecal methotrexate treatment in patients with anti-N-methyl-D-aspartate receptor encephalitis.
Showing 1-10 of 10